A Rapid Surveillance and Cohort Post-Marketing Safety Study to Evaluate the Safety of Respiratory Syncytial Virus Vaccine (ABRYSVO™) Exposure During Pregnancy in the United States (C3671027)

02/05/2024
26/01/2026
EU PAS number:
EUPAS1000000115
Study
Ongoing

ENCePP Code of conduct

Yes
Data sources

Data source(s), other

United States Food & Drug Administration (FDA) Sentinel System

Data sources (types)

Administrative healthcare records (e.g., claims)
Electronic healthcare records (EHR)
Use of a Common Data Model (CDM)

CDM mapping

Yes
Data quality specifications

Check conformance

Unknown

Check completeness

Unknown

Check stability

Unknown

Check logical consistency

Unknown
Data characterisation

Data characterisation conducted

Not applicable